Akorn Olopatadine Nasal Spray Recall: Stability Issues After Company Closure

Take action

Contact the company & request your remedy

Recalling firmAkorn, Inc.5605 Centerpoint Ct Ste A, N/A · Gurnee, IL 60031-5278

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Akorn has recalled all Olopatadine HCl Nasal Spray bottles (665 mcg, 30.5g) because the company went out of business and can no longer perform stability tests. This means the product's safety and effectiveness cannot be guaranteed.

Why it’s dangerous

The company went out of business and stopped stability testing, which means the product's safety and effectiveness over time cannot be confirmed. This could lead to unpredictable reactions or reduced effectiveness.

Who’s affected

People who have prescription Olopatadine HCl Nasal Spray bottles from Akorn. Those with the product are most at risk due to potential instability.

How to tell if you have this one

Check for Akorn Olopatadine HCl Nasal Spray bottles labeled 665 mcg, 30.5g, and prescription-only. All products from the manufacturer are affected.

Brand
Akorn
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Identify if your bottle has the label 'Olopatadine HCl Nasal Spray, 665 mcg, 30.5g' and is prescription-only.

✎ GovInfoNow

Questions people ask

Why was this product recalled?

The company went out of business and could no longer continue stability studies, so the product's safety and effectiveness cannot be guaranteed.

Do I need to stop using this product?

The recall does not specify a stop-use instruction, but the product's stability is unconfirmed due to the company's closure.

Is there a remedy for this recall?

The official notice states no remedy is provided.

Take action

Contact Akorn

We’ve drafted a message you can send Akorn to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0832-2023 — Akorn Akorn

Hello,

I own a Akorn that is covered by recall D-0832-2023 from Akorn.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0832-2023 (April 26, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0832-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Akorn, Inc. recalls Olopatadine HCl Nasal Spray, 665 mcg, 30.5 g bottles, Rx Only, Manufactured by: Akorn, Operating Company LLC, Gurnee,

Recall notice